Fundamentals and stats
An in-depth look to Vita Life Sciences Limited operating, investing, and financing activities
VLS free cash flow for H1 25 is 5.87 M AUD. For 2024, VLS free cash flow was 5.96 M AUD and operating cash flow was 6.16 M AUD.
H2 '17
H1 '18
H2 '18
H1 '19
H2 '19
H1 '20
H2 '20
H1 '21
H2 '21
H1 '22
H2 '22
H1 '23
H2 '23
H1 '24
H2 '24
H1 '25
−9.00 M
−4.50 M
0.00
4.50 M
9.00 M
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: AUD
H2 '17
Dec 2017
H1 '18
Jun 2018
H2 '18
Dec 2018
H1 '19
Jun 2019
H2 '19
Dec 2019
H1 '20
Jun 2020
H2 '20
Dec 2020
H1 '21
Jun 2021
H2 '21
Dec 2021
H1 '22
Jun 2022
H2 '22
Dec 2022
H1 '23
Jun 2023
H2 '23
Dec 2023
H1 '24
Jun 2024
H2 '24
Dec 2024
H1 '25
Jun 2025
TTM
Cash from operating activitiesYoY growth
8.42 M
+200.21%
2.66 M
−41.78%
3.50 M
−58.45%
6.60 M
+148.25%
10.09 M
Cash from investing activitiesYoY growth
−575.00 K
−371.31%
−8.00 K
+90.59%
−190.00 K
+66.96%
−730.00 K
−9,025.00%
−920.00 K
Cash from financing activitiesYoY growth
−1.83 M
+4.49%
433.00 K
—
−3.42 M
−87.26%
−5.13 M
−1,285.68%
−8.56 M
Free cash flowYoY growth
7.84 M
+192.43%
2.65 M
−40.86%
3.31 M
−57.82%
5.87 M
+121.44%
9.17 M